Impact of metabolic disorders on prostate cancer growth: Androgen and insulin resistance perspectives

BACKGROUND: A high prevalence of cancers in metabolic disorders, like metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM), recently has been noted, including prostate cancer (PC), which is androgen‐sensitive. However, the pathological relationship among testosterone and insulin and insulin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanase, Tashihiko, Kawanami, Takako, Tanaka, Tomoko, Tanabe, Makito, Nomiyama, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715889/
https://www.ncbi.nlm.nih.gov/pubmed/29259475
http://dx.doi.org/10.1002/rmb2.12039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715889/
https://www.ncbi.nlm.nih.gov/pubmed/29259475
http://dx.doi.org/10.1002/rmb2.12039

Ejemplares similares